Rigel and Medison announce Health Canada approval of Tavalisse, an oral medication for the treatment of adults with chronic immune thrombocytopenia

23 November 2020 - Rigel Pharmaceuticals and Medison Pharma today announced that Health Canada has approved the new drug submission ...

Read more →

Lilly's neutralising antibody bamlanivimab (LY-CoV555) receives interim authorisation from Health Canada as a treatment for COVID-19

20 November 2020 - Bamlanivimab emerged from collaboration between Lilly and Vancouver-based AbCellera. ...

Read more →

Knight Therapeutics announces filing of supplement to a new drug submission for Nerlynx (neratinib) to treat HER2-positive metastatic breast cancer

3 September 2020 - Knight Therapeutics Inc. announced filing of the supplement to a new drug submission (SNDS) of Nerlynx ...

Read more →

HLS Therapeutics announces Health Canada approval of Perseris for the treatment of schizophrenia

17 November 2020 - First once-monthly risperidone long-acting injectable used in the treatment of schizophrenia. ...

Read more →

Dupixent (dupilumab injection) now approved by Health Canada for patients with severe asthma

17 November 2020 - Only biologic approved in Canada to treat severe asthma with type 2 / eosinophilic phenotype, or oral ...

Read more →

Health Canada extends approval of Imvamune to immunisation against monkeypox and orthopox viruses

12 November 2020 - Bavarian Nordic announced today that Health Canada has expanded the approval of the Company’s non-replicating smallpox ...

Read more →

Promising new therapy for COVID-19 cleared by U.S., still under review by Health Canada

12 November 2020 - Antibody treatment co-developed by Canadian scientists has been approved by US FDA. ...

Read more →

Cystic Fibrosis Canada says 'life-changing' drug coming to Canada, but approval months away

11 November 2020 - The drug's manufacturer says it's moving forward with its cystic fibrosis medicines in Canada. ...

Read more →

Manufacturer moves to bring 'life-changing' cystic fibrosis drugs to Canada

10 November 2020 - A pharmaceutical company says it's taking steps to bring cystic fibrosis drugs to Canada in a ...

Read more →

Health Canada approves Maviret 8 week treatment duration for treatment naïve patients with genotype 3 compensated cirrhosis

10 November 2020 - Maviret (glecaprevir/pibrentasvir) is the only 8 week oral treatment approved for all hepatitis C virus genotypes. ...

Read more →

Health Canada approves Canada’s first HIV self test

3 November 2020 - For the first time, Canadians will have access to at-home HIV self test kits. bioLytical Laboratories ...

Read more →

Novartis' MONALEESA-7 Kisqali (ribociclib succinate) study demonstrated statistically significant improvement in overall survival in pre- and peri-menopausal women with HR+/HER2- advanced breast cancer

2 November 2020 - Novartis Pharmaceuticals Canada is pleased to announce that statistically significant overall survival  results for Kisqali (ribociclib succinate) ...

Read more →

Leo Pharma is withdrawing the drug Picato (ingenol mebutate), used to treat skin lesions, due to the potential increased risk of skin cancer

27 October 2020 - At Health Canada's request, Leo Pharma is withdrawing Picato from the Canadian market.  ...

Read more →

KYE Pharmaceuticals announces commercial availability of Firdapse in Canada

28 October 2020 - KYE Pharmaceuticals today announced an important milestone, Firdapse (amifampridine phosphate), the first amifampridine product approved in Canada, ...

Read more →

Incyte announces Health Canada acceptance of the new drug submission for pemigatinib as a treatment for patients with cholangiocarcinoma

26 October 2020 - Incyte today announced that Health Canada has accepted its new drug submission for pemigatinib, a selective fibroblast ...

Read more →